Research Keyword: diagnostic capacity

The Impact of the Fungal Priority Pathogens List on Medical Mycology: A Northern European Perspective

mycolabadmin

Fungal infections affect over a billion people worldwide but are often overlooked in healthcare. The World Health Organization recently created a priority list of dangerous fungi to help doctors and researchers focus their efforts. This review discusses how this list can improve diagnosis, testing, and treatment of fungal infections across Europe, while also highlighting the need for better training and awareness among healthcare workers.

Read More »

ESCMID-EFISG Survey on Diagnostic and Therapeutic Capacity for Invasive Fungal Infections in Belgium, the Netherlands, and Luxembourg: A Focus on High Azole Resistance

mycolabadmin

This survey examined how well hospitals in Belgium, the Netherlands, and Luxembourg can diagnose and treat serious fungal infections, which are particularly dangerous for people with weakened immune systems. The researchers found that while most hospitals can test fungal samples, not all have access to all necessary diagnostic tools, especially tests for detecting resistant fungi and identifying fungal co-infections. Many hospitals outsource their testing to other facilities, which can delay diagnosis and treatment, and some hospitals lack access to all recommended antifungal medications.

Read More »

Survey of clinical microbiology and infectious disease testing capabilities among institutions in Africa

mycolabadmin

This study surveyed laboratory facilities across Africa to understand what infectious disease tests are available. Researchers found that basic tests like bacterial identification are common, but advanced tests for viruses (other than HIV) and fungi are less available. The study highlights the need for investment in laboratory infrastructure to improve disease diagnosis and help countries respond to health emergencies.

Read More »

Diagnostic Capacity for Fungal Infections in Tertiary Hospitals in Nigeria and Ghana – An Onsite Baseline Audit of 9 Sites

mycolabadmin

Researchers audited fungal disease testing capabilities in major hospitals across Nigeria and Ghana. They found that most hospitals lack basic equipment, trained staff, and procedures needed to diagnose serious fungal infections like cryptococcal meningitis and invasive aspergillosis. The study highlights urgent needs for investment in laboratory infrastructure and personnel training to improve diagnosis of neglected fungal diseases in Africa.

Read More »

Eikenella corrodens isolated from pleural effusion: A case report

mycolabadmin

A 67-year-old patient developed a severe lung infection called empyema caused by a rare bacterium called Eikenella corrodens. Doctors drained infected fluid from the patient’s lungs and identified the bacterium through laboratory testing using special culture techniques and chemical tests. The patient received antibiotics but unfortunately died after 22 days despite treatment. This case highlights the importance of extended laboratory testing and improved diagnostic capabilities in hospitals to identify rare bacteria.

Read More »

ESCMID-EFISG Survey on Diagnostic and Therapeutic Capacity for Invasive Fungal Infections in Belgium, the Netherlands, and Luxembourg: A Focus on High Azole Resistance

mycolabadmin

This survey examined how well hospitals in Belgium, the Netherlands, and Luxembourg can diagnose and treat serious fungal infections, especially in patients whose immune systems are weakened. The researchers found that while most hospitals have good access to testing and antifungal medications, some important tests are still missing, and many hospitals send samples to other facilities for testing, which can delay treatment. Since this region has unusually high rates of fungal infections that resist common antifungal drugs, improving access to advanced diagnostic tests is crucial for patient survival.

Read More »
Scroll to Top